臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"hsu c"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 446-470 of 881 (36 Page(s) Totally)
<< < 13 14 15 16 17 18 19 20 21 22 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2020-12-02T02:35:51Z	Quality of life of lung cancer patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13	Chie W.-C.;Yang C.-H.;Hsu C.;Pan-Chyr Yang; Chie W.-C.; Yang C.-H.; Hsu C.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:35:46Z	Survival of stage IIIB/IV non-small cell lung cancer patients who received chemotherapy but did not participate in clinical trials	Kuo S.-H.;Yang C.-H.;Yu C.-J.;Hsu C.;Cheng A.-L.;Pan-Chyr Yang; Kuo S.-H.; Yang C.-H.; Yu C.-J.; Hsu C.; Cheng A.-L.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:35:37Z	Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status	Su W.-P.;Yang C.-H.;Yu C.-J.;Shih J.-Y.;Hsu C.;Pan-Chyr Yang; Su W.-P.; Yang C.-H.; Yu C.-J.; Shih J.-Y.; Hsu C.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:49Z	Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer	Yang C.-H.; Shih J.-Y.; Chen K.-C.; Yu C.-J.; Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Pan-Chyr Yang; Yang C.-H.; PAN-CHYR YANG et al.
臺大學術典藏	2020-12-02T02:34:36Z	Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment	Lin Z.-Z.; Hsu C.; Chang Y.-C.; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; PAN-CHYR YANG; Yang C.-H.
臺大學術典藏	2020-12-02T02:34:30Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	Hsu C.; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; PAN-CHYR YANG; Yang C.-H.
臺大學術典藏	2020-11-27T08:14:24Z	Weekly cisplatin, infusional high-dose 5-fluorouracil and leucovorin for advanced, recurrent and metastatic cervical carcinoma	Hsiao S.-M.;Chen C.-A.;Hsu C.;Lin H.-H.;Chang-Yao Hsieh;Wei L.-H.; Hsiao S.-M.; Chen C.-A.; Hsu C.; Lin H.-H.; CHANG-YAO HSIEH; Wei L.-H.
臺大學術典藏	2020-11-19T03:43:04Z	HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity	Huang C.-L.; Hsu H.-C.; PO-HUANG LEE; Wang S.-J.; Cheng A.-L.; Hsu C.; Hsu C.;Huang C.-L.;Hsu H.-C.;Po-Huang Lee;Wang S.-J.;Cheng A.-L.
臺大學術典藏	2020-11-19T03:42:56Z	Low-dose thalidomide treatment for advanced hepatocellular carcinoma	Hsu C.;Chen C.-N.;Chen L.-T.;Wu C.-Y.;Yang P.-M.;Lai M.-Y.;Po-Huang Lee;Cheng A.-L.; Hsu C.; Chen C.-N.; Chen L.-T.; Wu C.-Y.; Yang P.-M.; Lai M.-Y.; PO-HUANG LEE; Cheng A.-L.
臺大學術典藏	2020-11-19T03:19:32Z	Lc3 over-expression improves survival and attenuates lung injury through increasing autophagosomal clearance in septic mice	Lo S.; Yuan S.-S.F.; Hsu C.; Cheng Y.-J.; Chang Y.-F.; Hsueh H.-W.; PO-HUANG LEE; Hsieh Y.-C.
臺大學術典藏	2020-11-11T08:19:58Z	Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data	Campbell B.C.V.; Ma H.; Ringleb P.A.; Parsons M.W.; Churilov L.; Bendszus M.; Levi C.R.; Hsu C.; Kleinig T.J.; Fatar M.; Leys D.; Molina C.; Wijeratne T.; Curtze S.; Dewey H.M.; Barber P.A.; Butcher K.S.; De Silva D.A.; Bladin C.F.; Yassi N.; Pfaff J.A.R.; Sharma G.; Bivard A.; Desmond P.M.; Schwab S.; Schellinger P.D.; Yan B.; Mitchell P.J.; Serena J.; Toni D.; Thijs V.; Hacke W.; Davis S.M.; Donnan G.A.; Donnan G.A.; Davis S.M.; Parsons M.W.; Mitchell P.J.; Desmond P.M.; Oxley T.; Wu T.Y.; Shah D.; Zhao H.; Rodrigues E.; Salvaris P.; Alemseged F.; Ng F.; Williams C.; Ng J.-L.; Tu H.T.-H.; McDonald A.; Jackson D.; Tsoleridis J.; McCoy R.; Pesavento L.; Weir L.; Kleinig T.J.; Patel S.; Harvey J.; Mahadevan J.; Cheong E.; Balabanski A.; Waters M.; Drew R.; Cranefield J.; Mackey E.; Celestino S.; Low E.; Dewey H.M.; Bladin C.F.; Loh P.S.; Choi P.M.; Coote S.; Frost T.; Hogan K.; Ding C.; McModie S.; Zhang W.W.; Kyndt C.; Moore A.; Ross Z.; Liu J.; Miteff F.; Levi C.R.; Ang T.; Spratt N.; Garcia-Esperon C.; Kaauwai L.; Phan T.G.; Ly J.; Singhal S.; Clissold B.; Wong K.; Krause M.; Day S.; Sturm J.; O'Brian B.; Grimley R.; Simpson M.; Lee-Archer M.; Brodtmann A.; Coulton B.; Young D.; Wong A.A.; Muller C.; Field D.K.; Vallat W.; Maxwell V.; Bailey P.; Sabet A.; Mishra S.; Tan M.; George K.; Barber P.A.; Zhao L.; Meretoja A.; Tatlisumak T.; Sibolt G.; Tiainen M.; Koivu M.; Aarnio K.; Virta J.; Kasari O.; Eirola S.; Sun M.C.; Chen T.C.; Chuang C.S.; Chen Y.Y.; Lin C.M.; Ho S.C.; Hsiao P.M.; Tsai C.H.; Huang W.S.; Yang Y.W.; Huang H.Y.; Wang W.C.; Liu C.H.; Lu M.K.; Lu C.H.; Kung W.L.; Jiang S.K.; Wu Y.H.; Huang S.C.; Tseng C.H.; Tseng L.T.; Guo Y.C.; Lin D.; Hsu C.T.; Kuan C.W.; Hsu J.P.; Tsai H.T.; Suzuki M.; Sun Y.; Chen H.F.; Lu C.J.; Lin C.H.; Huang C.C.; Chu H.J.; Lee C.Y.; Chang W.H.; Lo Y.C.; Hsu Y.T.; CHIH-HAO CHEN; Sung P.S.; Ysai C.L.; Jeng J.S.; Tang S.C.; Tsai L.K.; Yeh S.J.; Lee Y.C.; Wang Y.T.; Chung T.C.; Hu C.J.; Chan L.; Chiou Y.W.; Lien L.M.; Yeh H.L.; Yeh J.H.; Chen W.H.; Lau C.L.; Chang A.; Lee I.Y.; Huang M.Y.; Lee J.T.; Peng G.S.; Lim J.C.; Hsu Y.D.; Lin C.C.; Cheng C.A.; Yen C.H.; Yang F.C.; Hsu C.H.; Sung Y.F.; Tsai C.K.; Tsai C.L.; Lee A.; Hankey G.; Blacker D.; Gerraty R.; Chen C.-I.; Hsu C.-S.; Cowley E.; Sallaberger M.; Snow B.; Kolbe J.; Stark R.; King J.; Macdonnell R.; Attia J.; D'Este C.; Bernhardt J.; Carey L.; Cadilhac D.; Anderson C.; Howells D.; Barber A.; Connelly A.; Macleod M.; O'Collins V.; Wilson W.; Macaulay L.; Bluhmki E.; Eschenfelder C.; Ringleb P.; Wahlgren N.; Wardlaw J.; Oppenheim C.; Lees K.R.; Kaste M.; von Kummer R.; Chatellier G.; Laage R.; Nu?ez X.; Ehrenkrona C.; Svenson A.-S.; Cove L.; Niederkorn K.; Gruber F.; Kapeller P.; Mikulik R.; Mas J.-L.; Berrouschot J.; Sobesky J.; K?hrmann M.; Steiner T.; Kessler C.; Dziewas R.; Poli S.; Althaus-Knaurer K.; Bovi P.; Rodriguez A.L.; Arenillas J.F.; Muir K.; Veltkamp R.; Dixit A.; Muddegowda G.; Kala L.; De Silva D.A.; Butcher K.S.; Byrnes G.; Peeters A.; Chalk J.B.; Fink J.N.; Kimber T.E.; Schultz D.; Hand P.J.; Frayne J.; Tress B.M.; McNeil J.; Burns R.; Johnston C.; Williams M.; EXTEND, ECASS-4; EPITHET Investigators
臺大學術典藏	2020-11-02T02:04:37Z	Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity	Kuo S.-H.; Yeh K.-H.; Chen L.-T.; Lin C.-W.; Hsu P.-N.; Hsu C.; MING-SHIANG WU; Tzeng Y.-S.; Tsai H.-J.; Wang H.-P.; Cheng A.-L.
臺大學術典藏	2020-10-23T03:49:06Z	Critical Trio Exome Benefits In-Time Decision-Making for Pediatric Patients with Severe Illnesses?	Wu E.-T.; Hwu W.-L.; Chien Y.-H.; Hsu C.; Chen T.-F.; Chen N.-Q.; Chou H.-C.; PO-NIEN TSAO; Fan P.-C.; Tsai I.-J.; Lin S.-P.; Hsieh W.-S.; Chang T.-M.; Chen C.-N.; Lee C.-H.; Chou Y.-Y.; Chiu P.-C.; Tsai W.-H.; Hsiung H.-C.; Lai F.; Lee N.-C.
臺大學術典藏	2020-10-20T01:45:47Z	Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies	TAI-CHUNG HUANG; Ko B.-S.; Tang J.-L.; Hsu C.; Chen C.-Y.; Tsay W.; Huang S.-Y.; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F.
臺大學術典藏	2020-09-30T08:49:47Z	Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis	Cheng M.-F.; YEN-WEN WU; Liu K.-L.; Yen R.-F.; Wu Y.-M.; Hsu C.; Chang Y.-T.; Tzen K.-Y.; Wang H.-P.
臺大學術典藏	2020-09-29T06:53:04Z	Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer	Kuo S.-H.; Cheng A.-L.; Tien Y.-W.; Yeh K.-H.; Hsu C.-H.; Hsu C.; Wu H.; Guo J.-C.; TING-CHUN KUO; Yang S.-H.
臺大學術典藏	2020-09-29T01:47:44Z	Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers	Yeh K.-H.; Cheng A.-L.; Yang J.C.-H.; Kao H.-F.; Chen I.-C.; Hsu C.; Chang S.-Y.; Chien S.-F.; YEE-CHUN CHEN; Hu F.-C.
臺大學術典藏	2020-09-23T07:36:15Z	Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis	Mei-Fang Cheng;Wu Y.-W.;Liu K.-L.;Yen R.-F.;Wu Y.-M.;Hsu C.;Chang Y.-T.;Tzen K.-Y.;Wang H.-P.; MEI-FANG CHENG; Wu Y.-W.; Liu K.-L.; Yen R.-F.; Wu Y.-M.; Hsu C.; Chang Y.-T.; Tzen K.-Y.; Wang H.-P.
臺大學術典藏	2020-09-23T06:22:40Z	Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate	Hsu C.; Hong R.-L.; Tzen C.-Y.; Jeng Y.-M.; RUOH-FANG YEN; Lin C.-H.; Lin C.-H.;Ruoh-Fang Yen;Jeng Y.-M.;Tzen C.-Y.;Hsu C.;Hong R.-L.
臺大學術典藏	2020-09-23T06:22:31Z	Diagnostic value of 18F-FDG-PET/CT in indeterminate infiltrative hepatic lesions in an endemic area of viral hepatitis	Cheng M.-F.; Wu Y.-W.; Liu K.-L.; RUOH-FANG YEN; Wu Y.-M.; Hsu C.; Chang Y.-T.; Tzen K.-Y.; Wang H.-P.
臺大學術典藏	2020-09-22T07:39:54Z	Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil	Chao-Yu Hsu ;Shen Y.-C. ;Yu C.-W. ;Hsu C. ;Hu F.-C. ;Hsu C.-H. ;Chen B.-B. ;Wei S.-Y. ;Cheng A.-L. ;Shih T.T.-F.; CHAO-YU HSU; Shen Y.-C.; Yu C.-W.; Hsu C.; Hu F.-C.; Hsu C.-H.; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2020-09-22T07:39:51Z	Dynamic contrast-enhanced MR imaging of advanced hepatocellular carcinoma: Comparison with the liver parenchyma and correlation with the survival of patients receiving systemic therapy	Shih T.T.-F.; Cheng A.-L.; Hsu C.-H.; Hsu C.; Liang P.-C.; Chen B.-B.; CHAO-YU HSU; Yu C.-W.
臺大學術典藏	2020-09-22T07:39:50Z	Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma	Chen B.-B.;Chao-Yu Hsu;Yu C.-W.;Liang P.-C.;Hsu C.;Hsu C.-H.;Cheng A.-L.;Shih T.T.-F.; Chen B.-B.; CHAO-YU HSU; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; Cheng A.-L.; Shih T.T.-F.
臺大學術典藏	2020-08-14T03:15:33Z	Comparison of characteristics and transarterial chemoembolization outcomes in patients with unresectable hepatocellular carcinoma and different viral etiologies	Chen B.-B.; I-LUN SHIH; Wu C.-H.; Hsu C.; Chen C.-H.; Shih T.T.-F.; Liu K.-L.; Liang P.-C.
臺大學術典藏	2020-08-14T03:15:30Z	Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma	Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; I-LUN SHIH; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L.

Showing items 446-470 of 881 (36 Page(s) Totally)
<< < 13 14 15 16 17 18 19 20 21 22 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 0
	???header.visitor??? : 52803636 ???header.onlineuser??? : 607 ???header.sponsordeclaration???